Home › NDC Lookup › RxCUI directory › RxCUI 2560228

20 ML sodium benzoate 100 MG/ML / sodium phenylacetate 100 MG/ML Injection — RxCUI 2560228

Name: 20 ML sodium benzoate 100 MG/ML / sodium phenylacetate 100 MG/ML Injection (RxCUI 2560228)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2560228 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2560228

Official name20 ML sodium benzoate 100 MG/ML / sodium phenylacetate 100 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known assodium benzoate 10 % / sodium phenylacetate 10 % per 20 ML Injection; sodium benzoate 10 % / sodium phenylacetate 10 % in 20 ML Injection

FDA products mapped4

Package NDCs mapped4

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How 20 ML sodium benzoate 100 MG/ML / sodium phenyla... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 20 ML sodium benzoate 100 MG/ML / sodium phenylacetate 100 MG/ML Injection RxCUI 2560228 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 5

The active substance itself — no strength, form, or brand attached yet.
- Benzoate 70589 IN
- Phenylacetate 70619 IN
- Benzoate / phenylacetate 1008811 MIN
- Sodium benzoate 56455 PIN
- Sodium phenylacetate 56510 PIN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Benzoate / phenylacetate Injection 1731065 SCDF
- Sodium benzoate / sodium phenylacetate Injection 2647740 SCDFP
- Benzoate / phenylacetate Injectable Product 1152009 SCDG
- Sodium benzoate / sodium phenylacetate Injectable Product 2662540 SCDGP
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 2

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Sodium benzoate 100 MG/ML 984116 SCDC
- Sodium phenylacetate 100 MG/ML 984117 SCDC

Showing up to 8 concepts per family — 13 of 13 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Sodium benzoate 100 MG/ML SCDC · 984116
Sodium phenylacetate 100 MG/ML SCDC · 984117
Benzoate / phenylacetate Injection SCDF · 1731065
Sodium benzoate / sodium phenylacetate Injection SCDFP · 2647740
Benzoate / phenylacetate Injectable Product SCDG · 1152009
Sodium benzoate / sodium phenylacetate Injectable Product SCDGP · 2662540

📦 FDA Products & Package NDCs

4 products · 4 package NDCs

4 package NDCs map to RxCUI 2560228 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
68475-0513-01	1 VIAL in 1 CARTON (68475-513-01) / 20 mL in 1 VIAL	Sodium phenylacetate and Sodium benzoate	Navinta LLC	2025-12-06
70511-0102-20	1 VIAL, SINGLE-DOSE in 1 CARTON (70511-102-20) / 20 mL in 1...	Sodium Phenylacetate and Sodium Benzoate	MAIA PHARMACEUTICALS	2021-07-01
70710-1926-01	1 VIAL in 1 CARTON (70710-1926-1) / 20 mL in 1 VIAL	Sodium phenylacetate and Sodium benzoate	Zydus Pharmaceuticals USA Inc.	2023-09-19
72266-0236-01	1 VIAL, SINGLE-DOSE in 1 CARTON (72266-236-01) / 20 mL in 1...	Sodium Phenylacetate and Sodium Benzoate	FOSUN PHARMA USA INC	2021-11-14

Observed labelers: FOSUN PHARMA USA INC (1) · MAIA PHARMACEUTICALS (1) · Navinta LLC (1) · Zydus Pharmaceuticals USA Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.